This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCharles & Colvard（CDR0）株式概要Charles & Colvard, Ltd.は、ファイン・ジュエリー・カンパニーとして米国内外で事業を展開している。 詳細CDR0 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析キャッシュランウェイが1年未満である 意味のある時価総額がありません ( €5M )過去5年間で収益は年間44.3%減少しました。 株式の流動性は非常に低い すべてのリスクチェックを見るCDR0 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€1.9868.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-18m44m2016201920222025202620282031Revenue US$22.6mEarnings US$1.6mAdvancedSet Fair ValueView all narrativesCharles & Colvard, Ltd. 競合他社elumeoSymbol: XTRA:ELBMarket cap: €10.1mBijou Brigitte modische AccessoiresSymbol: XTRA:BIJMarket cap: €397.1mVereinigte FilzfabrikenSymbol: BST:VFFMarket cap: €15.8mAB SnaigeSymbol: BST:ZS4Market cap: €3.5m価格と性能株価の高値、安値、推移の概要Charles & Colvard過去の株価現在の株価US$1.9852週高値US$7.9052週安値US$1.98ベータ1.451ヶ月の変化0%3ヶ月変化-6.60%1年変化-74.78%3年間の変化-91.24%5年間の変化-83.91%IPOからの変化-96.40%最新ニュースお知らせ • Apr 25Charles & Colvard, Ltd.(OTCPK:CTHR) dropped from NASDAQ Composite IndexCharles & Colvard, Ltd. has been dropped from the Nasdaq Composite Indexお知らせ • Apr 23Charles & Colvard Announces Delisting from NasdaqCharles & Colvard, Ltd. announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC (“Nasdaq”), informing the Company that Nasdaq determined to suspend trading and delist the Company’s common stock (the “Common Stock”) from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a careful review of numerous factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with Nasdaq listing standards. Nasdaq is expected to file a Form 25-NSE (Notification of Removal from Listing) with the Securities and Exchange Commission relating to the delisting of the Common Stock. Suspension of trading of the Common Stock will occur at the opening of business on April 25, 2025. Following the delisting, the Company expects that the Common Stock will be quoted on the OTC Experts Market. No assurances can be provided, however, that a trading market in the Common Stock in any over-the-counter market will be maintained.お知らせ • Mar 04Charles & Colvard Receives Expected Nasdaq Notice Regarding Delayed Form 10-QCharles & Colvard, Ltd. announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the ‘Listing Rule’), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company’s plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. Nasdaq has informed the Company that it must submit an update to its original plan of compliance no later than March 12, 2025 and that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to April 14, 2025. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The Company is working diligently to complete its delinquent periodic reports as promptly as practicable and regain compliance with the Listing Rule.お知らせ • Feb 19Charles & Colvard, Ltd. announced delayed 10-Q filingOn 02/18/2025, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 25Charles & Colvard, Ltd. Announces the Resignation of Benedetta Casamento from the Board of DirectorsOn January 20, 2025, Benedetta Casamento resigned from the Board of Directors of Charles & Colvard, Ltd. Her resignation from the Board was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.お知らせ • Nov 28Charles & Colvard, Ltd. Receives Non-Compliance Letter from NasdaqOn November 21, 2024, Charles & Colvard, Ltd. (the Company") received a notice (the Notice") from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the SEC"). The Form 10-Q was due on November 14, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on November 15, 2024. The Notice states that the Company has until December 17, 2024, to regain compliance with the Listing Rule or to submit a plan to regain compliance with the Listing Rule (the Plan"). If Nasdaq accepts the Company's Plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025, to file its Form 10-K and Form 10-Q to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company is working diligently to complete its Form 10-K and Form 10-Q and plans to file its Form 10-K and Form 10-Q as promptly as practicable to regain compliance with the Listing Rule.最新情報をもっと見るRecent updatesお知らせ • Apr 25Charles & Colvard, Ltd.(OTCPK:CTHR) dropped from NASDAQ Composite IndexCharles & Colvard, Ltd. has been dropped from the Nasdaq Composite Indexお知らせ • Apr 23Charles & Colvard Announces Delisting from NasdaqCharles & Colvard, Ltd. announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC (“Nasdaq”), informing the Company that Nasdaq determined to suspend trading and delist the Company’s common stock (the “Common Stock”) from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a careful review of numerous factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with Nasdaq listing standards. Nasdaq is expected to file a Form 25-NSE (Notification of Removal from Listing) with the Securities and Exchange Commission relating to the delisting of the Common Stock. Suspension of trading of the Common Stock will occur at the opening of business on April 25, 2025. Following the delisting, the Company expects that the Common Stock will be quoted on the OTC Experts Market. No assurances can be provided, however, that a trading market in the Common Stock in any over-the-counter market will be maintained.お知らせ • Mar 04Charles & Colvard Receives Expected Nasdaq Notice Regarding Delayed Form 10-QCharles & Colvard, Ltd. announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the ‘Listing Rule’), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company’s plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. Nasdaq has informed the Company that it must submit an update to its original plan of compliance no later than March 12, 2025 and that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to April 14, 2025. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The Company is working diligently to complete its delinquent periodic reports as promptly as practicable and regain compliance with the Listing Rule.お知らせ • Feb 19Charles & Colvard, Ltd. announced delayed 10-Q filingOn 02/18/2025, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 25Charles & Colvard, Ltd. Announces the Resignation of Benedetta Casamento from the Board of DirectorsOn January 20, 2025, Benedetta Casamento resigned from the Board of Directors of Charles & Colvard, Ltd. Her resignation from the Board was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.お知らせ • Nov 28Charles & Colvard, Ltd. Receives Non-Compliance Letter from NasdaqOn November 21, 2024, Charles & Colvard, Ltd. (the Company") received a notice (the Notice") from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the SEC"). The Form 10-Q was due on November 14, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on November 15, 2024. The Notice states that the Company has until December 17, 2024, to regain compliance with the Listing Rule or to submit a plan to regain compliance with the Listing Rule (the Plan"). If Nasdaq accepts the Company's Plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025, to file its Form 10-K and Form 10-Q to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company is working diligently to complete its Form 10-K and Form 10-Q and plans to file its Form 10-K and Form 10-Q as promptly as practicable to regain compliance with the Listing Rule.お知らせ • Nov 16Charles & Colvard, Ltd. announced delayed 10-Q filingOn 11/15/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Oct 25Charles & Colvard Receives Non-Compliance Letter from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)Charles & Colvard, Ltd. (‘Charles & Colvard’ or the ‘Company’) announced that on October 18, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the ‘Listing Rule’), as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the ‘Form 10-K’), with the Securities and Exchange Commission (the ‘SEC’). The Form 10-K was due on September 30, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on October 1, 2024. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days, or until December 17, 2024, to regain compliance with the Listing Rule or to submit to Nasdaq a plan to regain compliance with the Listing Rule (the ‘Plan’). If Nasdaq accepts the Company's Plan, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025 to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Company is working diligently to complete its Form 10-K and plans to file its Form 10-K as promptly as practicable to regain compliance with the Listing Rule.お知らせ • Oct 02Charles & Colvard, Ltd. announced delayed annual 10-K filingOn 10/01/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • May 16Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued ListingCharles & Colvard, Ltd. (the ‘Company’) announced that the company's board of directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the ‘Reverse Stock Split’), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the ‘Effective Date’). The Reverse Stock Split is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. The Company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on May 17, 2024 with a new CUSIP number of 159765205. The ticker symbol for the Company stock will remain ‘CTHR.’ The Company's shareholders at a special meeting held on May 7, 2024, approved a proposal to amend the Company's Restated Articles of Incorporation to effect a Reverse Stock Split at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board of Directors in its sole discretion.Reported Earnings • May 03Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)Third quarter 2024 results: US$0.12 loss per share (improved from US$0.28 loss in 3Q 2023). Revenue: US$5.26m (down 21% from 3Q 2023). Net loss: US$3.63m (loss narrowed 57% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.お知らせ • Apr 24Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024Charles & Colvard, Ltd. announced that they will report Q3, 2024 results After-Market on May 02, 2024New Risk • Apr 04New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.16m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.9m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (€9.16m market cap, or US$9.95m).Reported Earnings • Feb 14Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)Second quarter 2024 results: US$0.094 loss per share (further deteriorated from US$0.034 loss in 2Q 2023). Revenue: US$7.91m (down 24% from 2Q 2023). Net loss: US$2.87m (loss widened 175% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance.お知らせ • Feb 07Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024Charles & Colvard, Ltd. announced that they will report Q2, 2024 results After-Market on Feb 13, 2024Board Change • Dec 28Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Dec 15Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price RequirementAs previously disclosed, on June 12, 2023, Charles & Colvard, Ltd. (the ‘Company’) received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days (the ‘Minimum Bid Price Requirement’). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had 180 calendar days, or until December 11, 2023, to regain compliance with the Minimum Bid Price Requirement. On December 12, 2023 the Company received a notification letter from Nasdaq’s Listing Qualifications Department indicating that, while the Company has not regained compliance with the Minimum Bid Price Requirement, it is eligible for an additional 180-day grace period, or until June 10, 2024, to regain compliance with the Minimum Bid Price Requirement (the ‘December Notice’). To regain compliance, any time before June 10, 2024, the bid price of the Company’s common stock must close at a $1.00 per share or more for a minimum of 10 consecutive business days. Nasdaq’s determination to grant an additional 180-day grace period is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s written notice to Nasdaq on December 11, 2023 of its intention to cure the deficiency during the additional 180 calendar day compliance period, which compliance could be achieved by effecting a reverse stock split, if necessary. If the Company does not regain compliance by June 10, 2024, the Company expects that Nasdaq will provide written notification that the Company’s common stock will be delisted. At that time, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. The December Notice has no effect on the listing or trading of the Company’s common stock at this time. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement.お知らせ • Nov 01Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023Charles & Colvard, Ltd. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023お知らせ • Oct 28Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville, Morrisville North Carolina United States Agenda: To consider elect five nominees described in the proxy statement to the Board of Directors; to consider ratify the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending June 30, 2024; to consider vote, on an advisory (nonbinding) basis, to approve executive compensation; and to consider transact such other business as may properly come before the meeting or any adjournment thereof.お知らせ • Oct 11Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023Charles & Colvard, Ltd. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Oct 12, 2023お知らせ • Oct 01Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023Charles & Colvard, Ltd. provided earnings guidance for the fiscal year ended June 30, 2023. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company expects to report net sales decreased by 31% to $29.9 million for the fiscal year ended June 30, 2023 compared to net sales of $43.1 million for the fiscal year ended June 30, 2022. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company will report a net loss for the fiscal year ended June 30, 2023 that is a significant change compared to net income of $2.4 million reported for the year ended June 30, 2022.Board Change • Jul 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 16Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2)On June 12, 2023, Charles & Colvard, Ltd. received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 11, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before December 11, 2023, the bid price of the Company’s common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On December 11, 2023, if the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements.Recent Insider Transactions • May 11Insider recently bought €185k worth of stockOn the 5th of May, Carlos Valadez bought around 215k shares on-market at roughly €0.86 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €1.5m. Insiders have collectively bought €1.8m more in shares than they have sold in the last 12 months.Reported Earnings • May 07Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022)Third quarter 2023 results: US$0.28 loss per share (down from US$0.011 profit in 3Q 2022). Revenue: US$6.64m (down 32% from 3Q 2022). Net loss: US$8.40m (down US$8.73m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • Apr 13Insider recently bought €1.5m worth of stockOn the 6th of April, Carlos Valadez bought around 2m shares on-market at roughly €0.95 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.6m more in shares than they have sold in the last 12 months.Reported Earnings • Feb 05Second quarter 2023 earnings released: US$0.034 loss per share (vs US$0.039 profit in 2Q 2022)Second quarter 2023 results: US$0.034 loss per share (down from US$0.039 profit in 2Q 2022). Revenue: US$10.4m (down 25% from 2Q 2022). Net loss: US$1.04m (down 189% from profit in 2Q 2022). Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Jan 20Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023Charles & Colvard, Ltd. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Feb 02, 2023お知らせ • Dec 26Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid PriceOn December 19, 2022, Charles & Colvard, Ltd. ("the Company") received a notification letter from Nasdaq's Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company's common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before June 19, 2023, the bid price of the Company's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On June 19, 2023, if the Company’s meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements.Reported Earnings • Nov 05First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022)First quarter 2023 results: US$0.029 loss per share (down from US$0.028 profit in 1Q 2022). Revenue: US$7.37m (down 28% from 1Q 2022). Net loss: US$890.2k (down 208% from profit in 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 7.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Oct 21Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022Charles & Colvard, Ltd. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2022お知らせ • Oct 07Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New ColorCharles & Colvard, Ltd. announced with three major launches unveiled in three months time, their latest announcement - new lab grown precious gemstones in color - is another big milestone for the company and adds a colorful new dimension to their already impressive Made, Not Mined™ fine jewelry repertoire. Featuring lab grown ruby, sapphire, and emerald gemstones, the new conscious color collection also includes Caydia lab grown diamonds and showcases the above-ground stones with artistic silhouettes and higher carat designs. With dynamic movement and bold pops of color, these new pieces showcase lab grown precious gemstones that are manmade and graded by certified GIA experts to meet their superior AAA quality. Besides the obvious benefits to mother earth, the growing of precious gemstones allows for the color to be highly curated and produces clarity and polish standards of an excellent grading. (Something mined gemstones can rarely tout.) Made for the fashion-forward woman who has no desire to blend in - these colorful new pieces are perfectly timed with a recent runway fashion appetite that Vogue and other fashion magazines have referred to as an "uncontainable maximalist" style.お知らせ • Oct 01Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville North Carolina 27560 Carolina United States Agenda: To elect five nominees described in the proxy statement to the Board of Directors; to ratify the appointment of BDO USA, LLP as independent registered public accounting firm for the fiscal year ending June 30, 2023; to vote, on an advisory (nonbinding) basis, to approve executive compensation; and to transact such other business as may properly come before the meeting or any adjournment thereof.お知らせ • Sep 16Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's BandsCharles & Colvard, Ltd. announced Fresh off a Couture Collection launch that showcased their Caydia® lab grown diamonds in astounding carat weights and dramatic new silhouettes - Charles & Colvard is once again turning heads. This time, with their first ever line of men's diamond fashion bands. Featuring Caydia® lab grown diamonds and 14K recycled yellow and white gold, this sleek new line will join their acclaimed Signature Collection and give yet another glimpse into a bold and exciting new direction for the company already beloved for their Made, Not Mined™ bridal fine jewelry. While Charles & Colvard has no desire to slow down its contribution to wedding ring categories, it does plan to vastly expand its presence in the lab grown diamond fashion jewelry market. On a mission to become one of the elite destinations for lab grown diamond jewelry - these men's bands exemplify the brand's ability to marry traditional shapes with refined design. With staunch lines and mixed precious metals, these bands were engineered to balance traditional masculinity and modern sophistication. Bold and geometric, they command attention while remaining versatile and practical enough for everyday wear. Launched as part of the company's esteemed Signature Collection, each band features the company's patented signature star emblem inside the shank. Intended just for the wearer to know it's there – it's a powerful reminder to never compromise on standards. The company's commitment to using exclusively Made, Not Mined™ gemstones and 100% recycled precious metals is what sets them apart in the industry. While conscious bridal consumers have been aware of the brand since they began nearly 30 years ago, the Research Triangle Park, NC-based company won't be satisfied until their products are synonymous with all lab grown fine jewelry.Reported Earnings • Sep 03Full year 2022 earnings released: EPS: US$0.078 (vs US$0.44 in FY 2021)Full year 2022 results: EPS: US$0.078 (down from US$0.44 in FY 2021). Revenue: US$43.1m (up 9.8% from FY 2021). Net income: US$2.37m (down 82% from FY 2021). Profit margin: 5.5% (down from 33% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 9.7% compared to a 13% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Aug 19Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022Charles & Colvard, Ltd. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Sep 01, 2022お知らせ • Aug 18Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture CollectionA brand on the move, Charles & Colvard is giving the luxury industry a glimpse of what the future of fine jewelry looks like with their new Couture Collection. Responsibly crafted using Caydia® lab grown diamonds and recycled precious metals, the 50-piece collection features rings, bracelets, and earnings in staggering carat weights and design combinations that prove luxury fine jewelry can still be conscious. From 10-carat chandelier drop earrings, to double and triple stacked geometric eternity bands, and jaw-dropping 12- and 13-carat alternating tennis bracelets – the collection is intended for couture brides, red carpet fashion, celebrities, or anyone looking for high-carat conscious couture. Adding to their already-impressive repertoire of made, not mined™ fine jewelry – the company has their sights on becoming one of the top destinations for lab grown diamond jewelry. A stunning showcase of abstract silhouettes and dramatic lines that feature new pear, baguette, and marquise cuts, this collection certainly makes a case for why they should be. Their approach – using exclusively made, not mined gemstones – has been a popular choice that is gaining traction for nearly three decades. They've used that time to perfect their craftsmanship and now consider themselves an industry leader in the lab grown space. Building a fine jewelry company that's motivated by conscience, O'Connell says it's time the industry redefines what high couture jewelry looks like and where they're looking to buy it.お知らせ • Jun 26Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth IndexCharles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth IndexRecent Insider Transactions • May 28Independent Chairman recently bought €96k worth of stockOn the 26th of May, Neal Goldman bought around 79k shares on-market at roughly €1.22 per share. This was the largest purchase by an insider in the last 3 months. Neal has been a buyer over the last 12 months, purchasing a net total of €103k worth in shares.Reported Earnings • May 06Third quarter 2022 earnings released: EPS: US$0.011 (vs US$0.035 in 3Q 2021)Third quarter 2022 results: EPS: US$0.011 (down from US$0.035 in 3Q 2021). Revenue: US$9.75m (up 3.3% from 3Q 2021). Net income: US$338.5k (down 67% from 3Q 2021). Profit margin: 3.5% (down from 11% in 3Q 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 13% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • May 06Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its shares. The program will be funded by cash on hand and cash generated by operations. The program will expire on April 29, 2025.お知らせ • Apr 22Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022Charles & Colvard, Ltd. announced that they will report Q3, 2022 results Pre-Market on May 05, 2022Reported Earnings • Feb 04Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beatSecond quarter 2022 results: EPS: US$0.039 (down from US$0.087 in 2Q 2021). Revenue: US$13.8m (up 13% from 2Q 2021). Net income: US$1.17m (down 54% from 2Q 2021). Profit margin: 8.5% (down from 21% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 5.6%, compared to a 5.2% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 09First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: US$10.3m (up 30% from 1Q 2021). Net income: US$827.0k (down 5.4% from 1Q 2021). Profit margin: 8.0% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 51% per year.Reported Earnings • Sep 07Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$39.2m (up 34% from FY 2020). Net income: US$12.8m (up US$19.0m from FY 2020). Profit margin: 33% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$2.66, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Luxury industry in Europe. Total returns to shareholders of 198% over the past three years.Is New 90 Day High Low • Mar 03New 90-day high: €2.10The company is up 118% from its price of €0.96 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period.Is New 90 Day High Low • Feb 10New 90-day high: €1.95The company is up 122% from its price of €0.88 on 11 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 1.0% over the same period.Reported Earnings • Feb 06Second quarter 2021 earnings released: EPS US$0.087 (vs US$0.028 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$12.1m (up 14% from 2Q 2020). Net income: US$2.52m (up 209% from 2Q 2020). Profit margin: 21% (up from 7.6% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 06Revenue beats expectationsRevenue exceeded analyst estimates by 7.5%. Over the next year, revenue is forecast to grow 16%, compared to a 10% growth forecast for the Luxury industry in Germany.お知らせ • Jan 22Charles & Colvard, Ltd. to Report Q2, 2021 Results on Feb 04, 2021Charles & Colvard, Ltd. announced that they will report Q2, 2021 results After-Market on Feb 04, 2021Is New 90 Day High Low • Jan 19New 90-day high: €1.11The company is up 53% from its price of €0.72 on 21 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 6.0% over the same period.Is New 90 Day High Low • Dec 11New 90-day high: €1.04The company is up 82% from its price of €0.57 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period.お知らせ • Dec 04Charles & Colvard Regains Compliance with Nasdaq Minimum Bid Price Listing RequirementCharles & Colvard, Ltd. announced that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from the Nasdaq Listing Qualifications Department noted that as of November 27, 2020, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business days. Therefore, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.Recent Insider Transactions • Nov 19Independent Director recently bought €75k worth of stockOn the 12th of November, Ollin Sykes bought around 87k shares on-market at roughly €0.86 per share. In the last 3 months, they made an even bigger purchase worth €115k. Insiders have collectively bought €256k more in shares than they have sold in the last 12 months.Analyst Estimate Surprise Post Earnings • Nov 07Revenue beats expectationsRevenue exceeded analyst estimates by 39%. Over the next year, revenue is expected to shrink by 5.9% compared to a 6.6% growth forecast for the Luxury industry in Germany.Reported Earnings • Nov 07First quarter 2021 earnings released: EPS US$0.03The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$7.93m (up 4.2% from 1Q 2020). Net income: US$874.3k (up 322% from 1Q 2020). Profit margin: 11% (up from 2.7% in 1Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Nov 07New 90-day high: €0.83The company is up 42% from its price of €0.59 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 12% over the same period.Is New 90 Day High Low • Oct 07New 90-day high: €0.80The company is up 34% from its price of €0.59 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 15% over the same period.Recent Insider Transactions • Sep 19Independent Director recently bought €115k worth of stockOn the 16th of September, Ollin Sykes bought around 177k shares on-market at roughly €0.65 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €177k more in shares than they have sold in the last 12 months.お知らせ • Aug 21Charles & Colvard, Ltd. to Report Q4, 2020 Results on Sep 03, 2020Charles & Colvard, Ltd. announced that they will report Q4, 2020 results at 5:00 PM, Eastern Standard Time on Sep 03, 2020株主還元CDR0DE LuxuryDE 市場7D0%5.7%3.2%1Y-74.8%-21.9%2.5%株主還元を見る業界別リターン: CDR0過去 1 年間で-21.9 % の収益を上げたGerman Luxury業界を下回りました。リターン対市場: CDR0は、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is CDR0's price volatile compared to industry and market?CDR0 volatilityCDR0 Average Weekly Movementn/aLuxury Industry Average Movement4.8%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%安定した株価: CDR0 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 過去 1 年間のCDR0のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト199549Don O'Connellwww.charlesandcolvard.comCharles & Colvard, Ltd.は、ファイン・ジュエリー・カンパニーとして米国内外で事業を展開している。同社は、オンライン・チャンネルとトラディショナル・チャンネルの2つのセグメントで事業を展開している。同社は、Charles & Colvard Created Moissaniteブランドのモアッサナイト・ジュエリーや完成品のモアッサナイト・ジュエリー、Forever Oneブランドのプレミアム・モアッサナイト・ジュエリーの製造、販売、流通を行っている。また、Caydiaブランドでラボグロウンダイヤモンドとラボグロウンダイヤモンドを使用したジュエリーの販売も行っている。卸売業者、製造業者、小売業者、デザイナーには卸売価格で、最終消費者にはcharlesandcolvard.comやmoissaniteoutlet.com、第三者のオンラインマーケットプレイス、ドロップシッピング、その他のeコマース、卸売・小売顧客向けのCharles & Colvard Signature Showroomやcharlesandcolvarddirect.comを通じて小売価格で販売している。Charles & Colvard, Ltd.は1995年に設立され、ノースカロライナ州モリスビルに本社を置いている。もっと見るCharles & Colvard, Ltd. 基礎のまとめCharles & Colvard の収益と売上を時価総額と比較するとどうか。CDR0 基礎統計学時価総額€5.00m収益（TTM）-€16.75m売上高(TTM)€21.68m0.2xP/Sレシオ-0.3xPER（株価収益率CDR0 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CDR0 損益計算書（TTM）収益US$23.68m売上原価US$16.81m売上総利益US$6.87mその他の費用US$25.16m収益-US$18.29m直近の収益報告Mar 31, 2024次回決算日該当なし一株当たり利益（EPS）-6.03グロス・マージン29.02%純利益率-77.23%有利子負債／自己資本比率1.6%CDR0 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/08/13 17:08終値2024/05/16 00:00収益2024/03/31年間収益2023/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Charles & Colvard, Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Alex FuhrmanCraig-Hallum Capital Group LLCMatthew KorandaRoth Capital PartnersJustin RuissSidoti & Company, LLC
お知らせ • Apr 25Charles & Colvard, Ltd.(OTCPK:CTHR) dropped from NASDAQ Composite IndexCharles & Colvard, Ltd. has been dropped from the Nasdaq Composite Index
お知らせ • Apr 23Charles & Colvard Announces Delisting from NasdaqCharles & Colvard, Ltd. announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC (“Nasdaq”), informing the Company that Nasdaq determined to suspend trading and delist the Company’s common stock (the “Common Stock”) from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a careful review of numerous factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with Nasdaq listing standards. Nasdaq is expected to file a Form 25-NSE (Notification of Removal from Listing) with the Securities and Exchange Commission relating to the delisting of the Common Stock. Suspension of trading of the Common Stock will occur at the opening of business on April 25, 2025. Following the delisting, the Company expects that the Common Stock will be quoted on the OTC Experts Market. No assurances can be provided, however, that a trading market in the Common Stock in any over-the-counter market will be maintained.
お知らせ • Mar 04Charles & Colvard Receives Expected Nasdaq Notice Regarding Delayed Form 10-QCharles & Colvard, Ltd. announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the ‘Listing Rule’), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company’s plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. Nasdaq has informed the Company that it must submit an update to its original plan of compliance no later than March 12, 2025 and that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to April 14, 2025. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The Company is working diligently to complete its delinquent periodic reports as promptly as practicable and regain compliance with the Listing Rule.
お知らせ • Feb 19Charles & Colvard, Ltd. announced delayed 10-Q filingOn 02/18/2025, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 25Charles & Colvard, Ltd. Announces the Resignation of Benedetta Casamento from the Board of DirectorsOn January 20, 2025, Benedetta Casamento resigned from the Board of Directors of Charles & Colvard, Ltd. Her resignation from the Board was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.
お知らせ • Nov 28Charles & Colvard, Ltd. Receives Non-Compliance Letter from NasdaqOn November 21, 2024, Charles & Colvard, Ltd. (the Company") received a notice (the Notice") from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the SEC"). The Form 10-Q was due on November 14, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on November 15, 2024. The Notice states that the Company has until December 17, 2024, to regain compliance with the Listing Rule or to submit a plan to regain compliance with the Listing Rule (the Plan"). If Nasdaq accepts the Company's Plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025, to file its Form 10-K and Form 10-Q to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company is working diligently to complete its Form 10-K and Form 10-Q and plans to file its Form 10-K and Form 10-Q as promptly as practicable to regain compliance with the Listing Rule.
お知らせ • Apr 25Charles & Colvard, Ltd.(OTCPK:CTHR) dropped from NASDAQ Composite IndexCharles & Colvard, Ltd. has been dropped from the Nasdaq Composite Index
お知らせ • Apr 23Charles & Colvard Announces Delisting from NasdaqCharles & Colvard, Ltd. announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC (“Nasdaq”), informing the Company that Nasdaq determined to suspend trading and delist the Company’s common stock (the “Common Stock”) from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a careful review of numerous factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with Nasdaq listing standards. Nasdaq is expected to file a Form 25-NSE (Notification of Removal from Listing) with the Securities and Exchange Commission relating to the delisting of the Common Stock. Suspension of trading of the Common Stock will occur at the opening of business on April 25, 2025. Following the delisting, the Company expects that the Common Stock will be quoted on the OTC Experts Market. No assurances can be provided, however, that a trading market in the Common Stock in any over-the-counter market will be maintained.
お知らせ • Mar 04Charles & Colvard Receives Expected Nasdaq Notice Regarding Delayed Form 10-QCharles & Colvard, Ltd. announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the ‘Listing Rule’), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company’s plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. Nasdaq has informed the Company that it must submit an update to its original plan of compliance no later than March 12, 2025 and that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to April 14, 2025. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The Company is working diligently to complete its delinquent periodic reports as promptly as practicable and regain compliance with the Listing Rule.
お知らせ • Feb 19Charles & Colvard, Ltd. announced delayed 10-Q filingOn 02/18/2025, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 25Charles & Colvard, Ltd. Announces the Resignation of Benedetta Casamento from the Board of DirectorsOn January 20, 2025, Benedetta Casamento resigned from the Board of Directors of Charles & Colvard, Ltd. Her resignation from the Board was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.
お知らせ • Nov 28Charles & Colvard, Ltd. Receives Non-Compliance Letter from NasdaqOn November 21, 2024, Charles & Colvard, Ltd. (the Company") received a notice (the Notice") from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the SEC"). The Form 10-Q was due on November 14, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on November 15, 2024. The Notice states that the Company has until December 17, 2024, to regain compliance with the Listing Rule or to submit a plan to regain compliance with the Listing Rule (the Plan"). If Nasdaq accepts the Company's Plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025, to file its Form 10-K and Form 10-Q to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company is working diligently to complete its Form 10-K and Form 10-Q and plans to file its Form 10-K and Form 10-Q as promptly as practicable to regain compliance with the Listing Rule.
お知らせ • Nov 16Charles & Colvard, Ltd. announced delayed 10-Q filingOn 11/15/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Oct 25Charles & Colvard Receives Non-Compliance Letter from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)Charles & Colvard, Ltd. (‘Charles & Colvard’ or the ‘Company’) announced that on October 18, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the ‘Listing Rule’), as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the ‘Form 10-K’), with the Securities and Exchange Commission (the ‘SEC’). The Form 10-K was due on September 30, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on October 1, 2024. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days, or until December 17, 2024, to regain compliance with the Listing Rule or to submit to Nasdaq a plan to regain compliance with the Listing Rule (the ‘Plan’). If Nasdaq accepts the Company's Plan, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025 to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Company is working diligently to complete its Form 10-K and plans to file its Form 10-K as promptly as practicable to regain compliance with the Listing Rule.
お知らせ • Oct 02Charles & Colvard, Ltd. announced delayed annual 10-K filingOn 10/01/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • May 16Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued ListingCharles & Colvard, Ltd. (the ‘Company’) announced that the company's board of directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the ‘Reverse Stock Split’), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the ‘Effective Date’). The Reverse Stock Split is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. The Company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on May 17, 2024 with a new CUSIP number of 159765205. The ticker symbol for the Company stock will remain ‘CTHR.’ The Company's shareholders at a special meeting held on May 7, 2024, approved a proposal to amend the Company's Restated Articles of Incorporation to effect a Reverse Stock Split at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board of Directors in its sole discretion.
Reported Earnings • May 03Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)Third quarter 2024 results: US$0.12 loss per share (improved from US$0.28 loss in 3Q 2023). Revenue: US$5.26m (down 21% from 3Q 2023). Net loss: US$3.63m (loss narrowed 57% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 24Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024Charles & Colvard, Ltd. announced that they will report Q3, 2024 results After-Market on May 02, 2024
New Risk • Apr 04New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.16m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.9m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (€9.16m market cap, or US$9.95m).
Reported Earnings • Feb 14Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)Second quarter 2024 results: US$0.094 loss per share (further deteriorated from US$0.034 loss in 2Q 2023). Revenue: US$7.91m (down 24% from 2Q 2023). Net loss: US$2.87m (loss widened 175% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 07Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024Charles & Colvard, Ltd. announced that they will report Q2, 2024 results After-Market on Feb 13, 2024
Board Change • Dec 28Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 15Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price RequirementAs previously disclosed, on June 12, 2023, Charles & Colvard, Ltd. (the ‘Company’) received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days (the ‘Minimum Bid Price Requirement’). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had 180 calendar days, or until December 11, 2023, to regain compliance with the Minimum Bid Price Requirement. On December 12, 2023 the Company received a notification letter from Nasdaq’s Listing Qualifications Department indicating that, while the Company has not regained compliance with the Minimum Bid Price Requirement, it is eligible for an additional 180-day grace period, or until June 10, 2024, to regain compliance with the Minimum Bid Price Requirement (the ‘December Notice’). To regain compliance, any time before June 10, 2024, the bid price of the Company’s common stock must close at a $1.00 per share or more for a minimum of 10 consecutive business days. Nasdaq’s determination to grant an additional 180-day grace period is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s written notice to Nasdaq on December 11, 2023 of its intention to cure the deficiency during the additional 180 calendar day compliance period, which compliance could be achieved by effecting a reverse stock split, if necessary. If the Company does not regain compliance by June 10, 2024, the Company expects that Nasdaq will provide written notification that the Company’s common stock will be delisted. At that time, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. The December Notice has no effect on the listing or trading of the Company’s common stock at this time. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement.
お知らせ • Nov 01Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023Charles & Colvard, Ltd. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023
お知らせ • Oct 28Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville, Morrisville North Carolina United States Agenda: To consider elect five nominees described in the proxy statement to the Board of Directors; to consider ratify the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending June 30, 2024; to consider vote, on an advisory (nonbinding) basis, to approve executive compensation; and to consider transact such other business as may properly come before the meeting or any adjournment thereof.
お知らせ • Oct 11Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023Charles & Colvard, Ltd. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Oct 12, 2023
お知らせ • Oct 01Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023Charles & Colvard, Ltd. provided earnings guidance for the fiscal year ended June 30, 2023. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company expects to report net sales decreased by 31% to $29.9 million for the fiscal year ended June 30, 2023 compared to net sales of $43.1 million for the fiscal year ended June 30, 2022. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company will report a net loss for the fiscal year ended June 30, 2023 that is a significant change compared to net income of $2.4 million reported for the year ended June 30, 2022.
Board Change • Jul 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 16Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2)On June 12, 2023, Charles & Colvard, Ltd. received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 11, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before December 11, 2023, the bid price of the Company’s common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On December 11, 2023, if the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements.
Recent Insider Transactions • May 11Insider recently bought €185k worth of stockOn the 5th of May, Carlos Valadez bought around 215k shares on-market at roughly €0.86 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €1.5m. Insiders have collectively bought €1.8m more in shares than they have sold in the last 12 months.
Reported Earnings • May 07Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022)Third quarter 2023 results: US$0.28 loss per share (down from US$0.011 profit in 3Q 2022). Revenue: US$6.64m (down 32% from 3Q 2022). Net loss: US$8.40m (down US$8.73m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • Apr 13Insider recently bought €1.5m worth of stockOn the 6th of April, Carlos Valadez bought around 2m shares on-market at roughly €0.95 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.6m more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 05Second quarter 2023 earnings released: US$0.034 loss per share (vs US$0.039 profit in 2Q 2022)Second quarter 2023 results: US$0.034 loss per share (down from US$0.039 profit in 2Q 2022). Revenue: US$10.4m (down 25% from 2Q 2022). Net loss: US$1.04m (down 189% from profit in 2Q 2022). Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Jan 20Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023Charles & Colvard, Ltd. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Feb 02, 2023
お知らせ • Dec 26Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid PriceOn December 19, 2022, Charles & Colvard, Ltd. ("the Company") received a notification letter from Nasdaq's Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company's common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before June 19, 2023, the bid price of the Company's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On June 19, 2023, if the Company’s meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements.
Reported Earnings • Nov 05First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022)First quarter 2023 results: US$0.029 loss per share (down from US$0.028 profit in 1Q 2022). Revenue: US$7.37m (down 28% from 1Q 2022). Net loss: US$890.2k (down 208% from profit in 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 7.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Oct 21Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022Charles & Colvard, Ltd. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2022
お知らせ • Oct 07Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New ColorCharles & Colvard, Ltd. announced with three major launches unveiled in three months time, their latest announcement - new lab grown precious gemstones in color - is another big milestone for the company and adds a colorful new dimension to their already impressive Made, Not Mined™ fine jewelry repertoire. Featuring lab grown ruby, sapphire, and emerald gemstones, the new conscious color collection also includes Caydia lab grown diamonds and showcases the above-ground stones with artistic silhouettes and higher carat designs. With dynamic movement and bold pops of color, these new pieces showcase lab grown precious gemstones that are manmade and graded by certified GIA experts to meet their superior AAA quality. Besides the obvious benefits to mother earth, the growing of precious gemstones allows for the color to be highly curated and produces clarity and polish standards of an excellent grading. (Something mined gemstones can rarely tout.) Made for the fashion-forward woman who has no desire to blend in - these colorful new pieces are perfectly timed with a recent runway fashion appetite that Vogue and other fashion magazines have referred to as an "uncontainable maximalist" style.
お知らせ • Oct 01Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville North Carolina 27560 Carolina United States Agenda: To elect five nominees described in the proxy statement to the Board of Directors; to ratify the appointment of BDO USA, LLP as independent registered public accounting firm for the fiscal year ending June 30, 2023; to vote, on an advisory (nonbinding) basis, to approve executive compensation; and to transact such other business as may properly come before the meeting or any adjournment thereof.
お知らせ • Sep 16Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's BandsCharles & Colvard, Ltd. announced Fresh off a Couture Collection launch that showcased their Caydia® lab grown diamonds in astounding carat weights and dramatic new silhouettes - Charles & Colvard is once again turning heads. This time, with their first ever line of men's diamond fashion bands. Featuring Caydia® lab grown diamonds and 14K recycled yellow and white gold, this sleek new line will join their acclaimed Signature Collection and give yet another glimpse into a bold and exciting new direction for the company already beloved for their Made, Not Mined™ bridal fine jewelry. While Charles & Colvard has no desire to slow down its contribution to wedding ring categories, it does plan to vastly expand its presence in the lab grown diamond fashion jewelry market. On a mission to become one of the elite destinations for lab grown diamond jewelry - these men's bands exemplify the brand's ability to marry traditional shapes with refined design. With staunch lines and mixed precious metals, these bands were engineered to balance traditional masculinity and modern sophistication. Bold and geometric, they command attention while remaining versatile and practical enough for everyday wear. Launched as part of the company's esteemed Signature Collection, each band features the company's patented signature star emblem inside the shank. Intended just for the wearer to know it's there – it's a powerful reminder to never compromise on standards. The company's commitment to using exclusively Made, Not Mined™ gemstones and 100% recycled precious metals is what sets them apart in the industry. While conscious bridal consumers have been aware of the brand since they began nearly 30 years ago, the Research Triangle Park, NC-based company won't be satisfied until their products are synonymous with all lab grown fine jewelry.
Reported Earnings • Sep 03Full year 2022 earnings released: EPS: US$0.078 (vs US$0.44 in FY 2021)Full year 2022 results: EPS: US$0.078 (down from US$0.44 in FY 2021). Revenue: US$43.1m (up 9.8% from FY 2021). Net income: US$2.37m (down 82% from FY 2021). Profit margin: 5.5% (down from 33% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 9.7% compared to a 13% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Aug 19Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022Charles & Colvard, Ltd. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Sep 01, 2022
お知らせ • Aug 18Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture CollectionA brand on the move, Charles & Colvard is giving the luxury industry a glimpse of what the future of fine jewelry looks like with their new Couture Collection. Responsibly crafted using Caydia® lab grown diamonds and recycled precious metals, the 50-piece collection features rings, bracelets, and earnings in staggering carat weights and design combinations that prove luxury fine jewelry can still be conscious. From 10-carat chandelier drop earrings, to double and triple stacked geometric eternity bands, and jaw-dropping 12- and 13-carat alternating tennis bracelets – the collection is intended for couture brides, red carpet fashion, celebrities, or anyone looking for high-carat conscious couture. Adding to their already-impressive repertoire of made, not mined™ fine jewelry – the company has their sights on becoming one of the top destinations for lab grown diamond jewelry. A stunning showcase of abstract silhouettes and dramatic lines that feature new pear, baguette, and marquise cuts, this collection certainly makes a case for why they should be. Their approach – using exclusively made, not mined gemstones – has been a popular choice that is gaining traction for nearly three decades. They've used that time to perfect their craftsmanship and now consider themselves an industry leader in the lab grown space. Building a fine jewelry company that's motivated by conscience, O'Connell says it's time the industry redefines what high couture jewelry looks like and where they're looking to buy it.
お知らせ • Jun 26Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth IndexCharles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index
Recent Insider Transactions • May 28Independent Chairman recently bought €96k worth of stockOn the 26th of May, Neal Goldman bought around 79k shares on-market at roughly €1.22 per share. This was the largest purchase by an insider in the last 3 months. Neal has been a buyer over the last 12 months, purchasing a net total of €103k worth in shares.
Reported Earnings • May 06Third quarter 2022 earnings released: EPS: US$0.011 (vs US$0.035 in 3Q 2021)Third quarter 2022 results: EPS: US$0.011 (down from US$0.035 in 3Q 2021). Revenue: US$9.75m (up 3.3% from 3Q 2021). Net income: US$338.5k (down 67% from 3Q 2021). Profit margin: 3.5% (down from 11% in 3Q 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 13% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • May 06Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its shares. The program will be funded by cash on hand and cash generated by operations. The program will expire on April 29, 2025.
お知らせ • Apr 22Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022Charles & Colvard, Ltd. announced that they will report Q3, 2022 results Pre-Market on May 05, 2022
Reported Earnings • Feb 04Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beatSecond quarter 2022 results: EPS: US$0.039 (down from US$0.087 in 2Q 2021). Revenue: US$13.8m (up 13% from 2Q 2021). Net income: US$1.17m (down 54% from 2Q 2021). Profit margin: 8.5% (down from 21% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 5.6%, compared to a 5.2% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 09First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: US$10.3m (up 30% from 1Q 2021). Net income: US$827.0k (down 5.4% from 1Q 2021). Profit margin: 8.0% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 51% per year.
Reported Earnings • Sep 07Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$39.2m (up 34% from FY 2020). Net income: US$12.8m (up US$19.0m from FY 2020). Profit margin: 33% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$2.66, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Luxury industry in Europe. Total returns to shareholders of 198% over the past three years.
Is New 90 Day High Low • Mar 03New 90-day high: €2.10The company is up 118% from its price of €0.96 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period.
Is New 90 Day High Low • Feb 10New 90-day high: €1.95The company is up 122% from its price of €0.88 on 11 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 1.0% over the same period.
Reported Earnings • Feb 06Second quarter 2021 earnings released: EPS US$0.087 (vs US$0.028 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$12.1m (up 14% from 2Q 2020). Net income: US$2.52m (up 209% from 2Q 2020). Profit margin: 21% (up from 7.6% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 06Revenue beats expectationsRevenue exceeded analyst estimates by 7.5%. Over the next year, revenue is forecast to grow 16%, compared to a 10% growth forecast for the Luxury industry in Germany.
お知らせ • Jan 22Charles & Colvard, Ltd. to Report Q2, 2021 Results on Feb 04, 2021Charles & Colvard, Ltd. announced that they will report Q2, 2021 results After-Market on Feb 04, 2021
Is New 90 Day High Low • Jan 19New 90-day high: €1.11The company is up 53% from its price of €0.72 on 21 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Dec 11New 90-day high: €1.04The company is up 82% from its price of €0.57 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period.
お知らせ • Dec 04Charles & Colvard Regains Compliance with Nasdaq Minimum Bid Price Listing RequirementCharles & Colvard, Ltd. announced that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from the Nasdaq Listing Qualifications Department noted that as of November 27, 2020, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business days. Therefore, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.
Recent Insider Transactions • Nov 19Independent Director recently bought €75k worth of stockOn the 12th of November, Ollin Sykes bought around 87k shares on-market at roughly €0.86 per share. In the last 3 months, they made an even bigger purchase worth €115k. Insiders have collectively bought €256k more in shares than they have sold in the last 12 months.
Analyst Estimate Surprise Post Earnings • Nov 07Revenue beats expectationsRevenue exceeded analyst estimates by 39%. Over the next year, revenue is expected to shrink by 5.9% compared to a 6.6% growth forecast for the Luxury industry in Germany.
Reported Earnings • Nov 07First quarter 2021 earnings released: EPS US$0.03The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$7.93m (up 4.2% from 1Q 2020). Net income: US$874.3k (up 322% from 1Q 2020). Profit margin: 11% (up from 2.7% in 1Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Nov 07New 90-day high: €0.83The company is up 42% from its price of €0.59 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 12% over the same period.
Is New 90 Day High Low • Oct 07New 90-day high: €0.80The company is up 34% from its price of €0.59 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 15% over the same period.
Recent Insider Transactions • Sep 19Independent Director recently bought €115k worth of stockOn the 16th of September, Ollin Sykes bought around 177k shares on-market at roughly €0.65 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €177k more in shares than they have sold in the last 12 months.
お知らせ • Aug 21Charles & Colvard, Ltd. to Report Q4, 2020 Results on Sep 03, 2020Charles & Colvard, Ltd. announced that they will report Q4, 2020 results at 5:00 PM, Eastern Standard Time on Sep 03, 2020
